ibrutinib,rituximab
abbvie,janssen
[' ibru', 'mantle,(-dismantle)', 'lymphoma']
1/2 triangle clinical trial results presented at #ash22 plenary session by dr martin dreyling ibrutinib added to induction and maintenance in mantle cell lymphoma 
MD, PhD. Hematologist in CHUAC (A Coruña-Spain). Leukemia,Bone Marrow Transplantation and CAR-T. Tweets and opinions are mine.